坐骨神経痛治療の世界市場

坐骨神経痛治療の世界市場は2030年までに8億4,800万米ドルに達する見込み

2024年に7億3,570万米ドルと推定される坐骨神経痛治療の世界市場は、2030年には8億4,800万米ドルに達し、分析期間2024-2030年のCAGRは2.4％で成長すると予測されます。本レポートで分析したセグメントの1つである急性坐骨神経痛治療は、CAGR 2.7％を記録し、分析期間終了時には5億240万米ドルに達すると予測されています。慢性坐骨神経痛治療分野の成長率は、分析期間中CAGR 1.6％と推定されます。

米国市場は2億50万米ドルと推定、中国はCAGR 4.7％で成長予測

米国の坐骨神経痛治療市場は、2024年に2億50万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを4.7%として、2030年までに1億6,270万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.9%と1.8%と予測されています。欧州では、ドイツがCAGR 1.3%で成長すると予測されています。

世界の「坐骨神経痛治療」市場- 主要動向と促進要因まとめ

坐骨神経痛が世界の医療システムで注目される理由とは？

坐骨神経の圧迫による放散性腰痛を特徴とする坐骨神経痛は、座りっぱなしのライフスタイル、高齢化、肥満率の上昇により、ますます蔓延しています。坐骨神経痛は、日常的な移動、労働生産性、生活の質に影響を及ぼします。この疾患は、生命を脅かすものではないが、多くの場合、長期の臨床的注意を必要とする慢性的な不快感をもたらします。デスクワークの増加やエルゴノミクスの悪化と相まって、認知度や診断の向上が坐骨神経痛治療の需要を牽引しています。患者は現在、即時的な痛みの緩和と長期的な機能回復を両立させる個別化された治療法を求めています。この疾患は、姿勢の悪い若年層から椎間板変性症の高齢者まで幅広い層に及ぶため、治療法は急速に拡大しています。世界中で年間数百万人が何らかの形で腰痛に悩まされており、坐骨神経痛の管理は、より広い筋骨格系疾患市場の中で焦点として浮上しています。

治療プロトコルを変える進歩とは？

技術革新は坐骨神経痛治療市場に革命をもたらし、対症療法から全体的な回復へとシフトしています。微小椎間板切除術や内視鏡脊椎手術のような低侵襲手術は、入院期間を短縮し、回復時間を改善しています。疼痛管理は、画像誘導注射、神経切除、脊髄刺激装置の使用により強化されています。理学療法は、デジタル理学療法アプリ、ウェアラブルモーションセンサー、AI駆動型姿勢矯正システムによって進化しています。PRP（多血小板血漿）や幹細胞療法などの再生医療によるアプローチは、神経や椎間板の根本的な損傷に対処するために人気を集めています。医薬品の選択肢も広がっており、新しい製剤は徐放性で非オピオイドの代替薬を提供しています。遠隔医療は、特に地方や高齢化した人々にとって、経過観察やリハビリテーションをより利用しやすくしています。これらの進歩を総合すると、より患者中心の、アウトカム志向のケア・パスウェイが可能になりつつあります。

ヘルスケアプロバイダーと消費者は市場力学にどのような影響を与えているか？

患者の嗜好は非侵襲的で個別化された治療計画へとシフトしており、医療提供者は集学的アプローチを採用するようになっています。病院は、神経科、整形外科、リハビリテーション科を統合した疼痛管理ユニットを建設しています。理学療法や非外科的介入などの治療に対する保険適用が拡大し、アクセスが広がっています。消費者直結型の医療プラットフォームは、患者に情報やセルフケアツールを提供し、治療の選択に影響を与えています。新興市場では、ヘルスケアインフラと可処分所得の増加により、これまで見過ごされていた慢性疾患の治療を求める人が増えています。医療提供者側では、償還政策とエビデンスに基づく治療ガイドラインが標準的なプロトコルを形成しつつあります。学術機関や研究病院も、新しい治療法やデジタルヘルスツールを試験的に導入し、イノベーションに貢献しています。医療提供者の戦略と消費者の行動との間のこうした相互作用は、市場の反応性を促進するフィードバック・ループを形成しています。

坐骨神経痛治療市場の成長は複数の要因によってもたらされる...

市場の成長を後押ししているのは、いくつかの連動した要因です。腰部障害の世界の発生率の上昇により、大規模かつ反復的な患者基盤が形成されつつあります。診断や治療方法の技術的進歩により、治療の有効性が高まり、医療介入に対する患者の嗜好が高まっています。鍼治療、ヨガ、水処理などの代替療法が受け入れられつつあり、治療エコシステムが多様化しています。インドやタイなどの国々では、保険償還の枠組みが整備され、脊椎治療を目的とした医療ツーリズムが増加しており、新市場が開拓されつつあります。整形外科専門クリニックの拡大とデジタルヘルス新興企業の参入は、治療をより身近なものにしています。企業による従業員の健康重視の高まりは、脊椎の健康に取り組む職場ウェルネス・プログラムの需要を押し上げています。これらの市場促進要因が相まって、坐骨神経痛治療市場の堅調なマルチチャネル成長が確実なものとなっています。

セグメント

タイプ（急性坐骨神経痛、慢性坐骨神経痛、その他のタイプ）、薬剤クラス（非ステロイド性抗炎症薬、ステロイド、抗うつ薬、その他の薬剤クラス別）、流通チャネル（病院薬局、小売・専門薬局、オンラインプロバイダー）

調査対象企業の例（注目の44社）

• Abbott Laboratories
• Alkem Laboratories Ltd.
• Amneal Pharmaceuticals LLC
• Aurobindo Pharma Ltd.
• Bayer AG
• Boston Scientific Corporation
• Bristol Myers Squibb
• Eliem Therapeutics
• Endo International plc
• Glenmark Pharmaceuticals Ltd.
• Johnson & Johnson
• Kolon Life Science, Inc.
• Medtronic plc
• Novartis AG
• Pfizer Inc.
• SCILEX Pharmaceuticals Inc.
• Seikagaku Corporation
• Sinfonia Biotherapeutics
• Sorrento Therapeutics, Inc.
• Teva Pharmaceutical Industries

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Sciatica Treatment Market to Reach US$848.0 Million by 2030

The global market for Sciatica Treatment estimated at US$735.7 Million in the year 2024, is expected to reach US$848.0 Million by 2030, growing at a CAGR of 2.4% over the analysis period 2024-2030. Acute Sciatica Treatment, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$502.4 Million by the end of the analysis period. Growth in the Chronic Sciatica Treatment segment is estimated at 1.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$200.5 Million While China is Forecast to Grow at 4.7% CAGR

The Sciatica Treatment market in the U.S. is estimated at US$200.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$162.7 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.3% CAGR.

Global "Sciatica Treatment" Market - Key Trends & Drivers Summarized

What Makes Sciatica a Growing Concern in Global Health Systems?

Sciatica, characterized by radiating lower back pain due to compression of the sciatic nerve, is becoming increasingly prevalent due to sedentary lifestyles, aging populations, and rising obesity rates. It impacts daily mobility, workforce productivity, and quality of life. The condition, although non-life-threatening, often results in chronic discomfort requiring prolonged clinical attention. Increased awareness and diagnosis, combined with the rise in desk-based occupations and poor ergonomics, are driving the demand for sciatica treatment. Patients are now seeking personalized therapies that combine immediate pain relief with long-term functional recovery. As the condition spans a broad demographic-from young adults with poor posture to elderly patients with degenerative disc disorders-the treatment landscape is expanding rapidly. With millions globally suffering from some form of lower back pain annually, sciatica management is emerging as a focal point within the broader musculoskeletal disorder market.

What Are the Advancements Reshaping Treatment Protocols?

Technological innovations are revolutionizing the sciatica treatment market, shifting it from symptom management to holistic recovery. Minimally invasive procedures like microdiscectomy and endoscopic spinal surgery are reducing hospital stays and improving recovery times. Pain management has been enhanced through the use of image-guided injections, nerve ablations, and spinal cord stimulators. Physical therapy is evolving with digital physiotherapy apps, wearable motion sensors, and AI-driven posture correction systems. Regenerative medicine approaches, such as PRP (platelet-rich plasma) and stem cell therapy, are gaining traction for addressing underlying nerve or disc damage. Pharmaceutical options are also expanding, with newer formulations offering sustained-release and non-opioid alternatives. Telemedicine has made follow-ups and rehabilitation more accessible, especially in rural and aging populations. Collectively, these advancements are enabling more patient-centric, outcome-oriented care pathways.

How Are Healthcare Providers and Consumers Influencing Market Dynamics?

Patient preferences are shifting toward non-invasive, personalized treatment plans, encouraging providers to adopt multidisciplinary approaches. Hospitals are building integrated pain management units that combine neurology, orthopedics, and rehabilitation. Increasing availability of insurance coverage for therapies like physiotherapy and non-surgical interventions is broadening access. Direct-to-consumer health platforms are empowering patients with information and self-care tools, influencing treatment choices. In emerging markets, rising healthcare infrastructure and disposable incomes are allowing more people to seek treatment for chronic conditions previously overlooked. On the provider side, reimbursement policies and evidence-based treatment guidelines are shaping standard protocols. Academic institutions and research hospitals are also contributing to innovation by piloting novel therapeutics and digital health tools. These interactions between provider strategies and consumer behaviors are forming a feedback loop driving market responsiveness.

The Growth In The Sciatica Treatment Market Is Driven By Several Factors...

Several interlinked factors are propelling market growth. Rising global incidence of lower back disorders is creating a large and recurring patient base. Technological advancements in diagnostics and treatment modalities are increasing care efficacy and patient preference for medical intervention. Growing acceptance of alternative therapies such as acupuncture, yoga, and hydrotherapy is diversifying the treatment ecosystem. Supportive reimbursement frameworks and increasing medical tourism for spinal care in countries like India and Thailand are opening new markets. Expansion of orthopedic specialty clinics and the entry of digital health startups are making treatment more accessible. Increasing focus on employee health by corporates is boosting demand for workplace wellness programs that address spinal health. These combined drivers are ensuring robust, multi-channel growth in the sciatica treatment market.

SCOPE OF STUDY:

The report analyzes the Sciatica Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Acute Sciatica, Chronic Sciatica, Other Types); Drug Class (Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants, Other Drug Classes); Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies, Online Providers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Abbott Laboratories
• Alkem Laboratories Ltd.
• Amneal Pharmaceuticals LLC
• Aurobindo Pharma Ltd.
• Bayer AG
• Boston Scientific Corporation
• Bristol Myers Squibb
• Eliem Therapeutics
• Endo International plc
• Glenmark Pharmaceuticals Ltd.
• Johnson & Johnson
• Kolon Life Science, Inc.
• Medtronic plc
• Novartis AG
• Pfizer Inc.
• SCILEX Pharmaceuticals Inc.
• Seikagaku Corporation
• Sinfonia Biotherapeutics
• Sorrento Therapeutics, Inc.
• Teva Pharmaceutical Industries

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Sciatica Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Sedentary Lifestyles and Aging Populations Propel Demand for Sciatica Treatments
  • Increasing Adoption of Non-Invasive Pain Management Therapies Strengthens Market for Physical Rehabilitation
  • Expanding Use of Spinal Injections and Nerve Block Techniques Throws the Spotlight on Interventional Treatments
  • Growth in Chiropractic and Alternative Therapies Fuels Demand for Integrated Pain Management Solutions
  • Rising Awareness of Early Diagnosis and Lifestyle Correction Sustains Market for Conservative Therapies
  • Surgical Innovations in Microdiscectomy and Minimally Invasive Techniques Drive Treatment Uptake
  • Workplace Wellness Programs Accelerate Demand for Preventive and Therapeutic Services
  • Expansion of Telemedicine and Virtual Physical Therapy Platforms Broadens Patient Access
  • Advances in Wearable Posture and Mobility Devices Support Sciatica Self-Management
  • Increasing Insurance Coverage for Physical Therapy and Pain Management Boosts Adoption
  • Cross-Specialty Collaboration Creates Multidisciplinary Treatment Opportunities
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Sciatica Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Sciatica Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Sciatica Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Sciatica Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Acute Sciatica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Acute Sciatica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Acute Sciatica by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Chronic Sciatica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Chronic Sciatica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Chronic Sciatica by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Online Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Online Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Online Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Retail & Specialty Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Retail & Specialty Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Retail & Specialty Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Non-Steroidal Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Non-Steroidal Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Non-Steroidal Anti-Inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Steroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Steroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Steroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Antidepressants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Antidepressants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Antidepressants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• JAPAN
  • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• CHINA
  • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• EUROPE
  • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Sciatica Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Sciatica Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Sciatica Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• FRANCE
  • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• GERMANY
  • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Sciatica Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Sciatica Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Sciatica Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• INDIA
  • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Sciatica Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Sciatica Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Sciatica Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Sciatica Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Sciatica Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Sciatica Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
• AFRICA
  • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030

IV. COMPETITION